Events & Presentations

First Quarter Financial Results Conference Call

Link to webcast

Kamada management will host an investment community conference call on Monday, May 9, 2016 at 8:30 a.m. Eastern time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 888-803-5993 (from within the U.S.), 706-634-5454 (from outside the U.S.) and entering the conference identification number: 5573974. The call will also be webcast live on the internet on the Company's website at www.kamada.com.

A replay of the call will be accessible two hours after its completion through May 15, 2016 by dialing 855-859-2056 (from within the U.S.) or 404-537-3406 (from outside the U.S.) and entering the conference identification number: 5573974. The call will also be archived for 90 days on the Company's website at www.kamada.com.

Bio Europe Spring 2016

BIO-Europe Spring® is the premier springtime partnering conference which annually attracts an international "who's who" from biotech, pharma and finance for three days of high caliber networking.

International Plasma Protein Congress

The IPPC is the premier conference in Europe for the plasma protein therapeutics industry. Take advantage of this event and join policy makers, regulators, industry leaders, physicians, scientists, and patient representatives from around the globe.

Kamada to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference

NESS ZIONA, Israel (February 5, 2016) – Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that the Company will participate at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference taking place February 10-11, 2016 in New York City. Amir London, the Company's Chief Executive Officer, will present a corporate overview on February 11^th from 12:30PM to 12:55PM. Mr. London's slide presentation will be available on the Company's website at www.kamada.com

The 18th Annual BIO CEO & Investor Conference 2016

Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities. Our therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma. Seasoned industry executives and analysts delve into timely and relevant business models, deal-making and investment trends on our business roundtables.

Kamada to Host Fourth Quarter and Year End 2015 Financial Results Conference Call

NESS ZIONA, Israel (January 27, 2016) – Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that it will release financial results for the three and twelve months ended December 31, 2015 prior to the open of the U.S. stock market open on Tuesday, February 2, 2016. Kamada management will host an investment community conference call on Tuesday, February 2, 2016 at 8:30 a.m. Eastern time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 888-803-5993 (from within the U.S.), 706-634-5454 (from outside the U.S.) or 1-809-315-362 (toll-free from Israel) and entering the conference identification number: 38830870. The call will also be webcast live here. A replay of the call will be accessible two hours after its completion through February 8, 2016 by dialing 855-859-2056 (from within the U.S.) or 404-537-3406 (from outside the U.S.) and entering the conference identification number: 38830870.

J.P. Morgan 34th Annual Healthcare Conference

J.P. Morgan conferences bring together corporate leaders, financial sponsors and institutional investors to explore market and sector trends.

Kamada to participate at the Bio Europe Spring Conference

About the Bio Europe Spring Conference, where the global biotech industry comes to partner. BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities.

Kamada to participate at the 33rd J.P. Morgan Annual Healthcare Conference January 2015

The 33rd Annual J.P. Morgan Healthcare Conference & Biotech Showcase 2015 will be held January 12-15, 2014 in San Francisco, California. The Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week which is widely viewed as setting the tone for the coming year. - See more at: http://globalbiodefense.com/event/j-p-morgan-annual-healthcare-conference/#sthash.fHzinGct.dpuf

Kamada to present at the Jefferies 2013 London Healthcare Conference

The 2013 conference is set to feature public and private leading global healthcare companies within the areas of pharmaceuticals, biotech, generics, medtech and healthcare services from the US, Central and Eastern Europe, Latin America, India, China, Japan, Egypt, Israel and Russia. This global gathering of institutional investors, private equity investors, VCs and leading executives will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.